Helen Chen

221 papers receiving 10.4k citations

Helen Chen's Hit Papers

Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia 2007 · 433 citations
4330+10+20Years since publication50010001.5k2.0k2.5k

Peers

Helen Chen
Comparison fields: 5 of 189
  • Cancer Research 1.5k
  • Oncology 1.9k
  • Molecular Biology 4.5k
  • Obstetrics and Gynecology 419
  • Hepatology 432
Replace Peter K. Gregersen with:
Peter K. Gregersen United States
Bruce J. Aronow United States
Haiying Zhang China
Soma Das United States
Xin Li China
Adam P. Dicker United States
Diether Lambrechts Belgium
Chun Zhang China
Lu Wang China
Zichen Wang United States
Helen Chen relative to Peter K. Gregersen United States Peter K. Gregersen's profile →
Citations per field
00.5×1.5×1.8×
Peter K. Gregersen · 1×
Citations per year

Countries citing papers authored by Helen Chen

Since Specialization
Citations

This map shows the geographic impact of Helen Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Chen more than expected).

Fields of papers citing papers by Helen Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Chen. The network helps show where Helen Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Helen Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Helen Chen Line = papers co-authored together Helen Chen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 239 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Hit paper breakdown →
19962853
2
The Carboxyl-terminal Domain(111–165) of Vascular Endothelial Growth Factor Is Critical for Its Mitogenic Potency
Hit paper breakdown →
1996508
3
Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia
Hit paper breakdown →
2007433
4 1996419
5 2006405
6 2008380
7 2007293
8 2016219
9 2005200
10 2013192
11 2000145
12 2004143
13 2020120
14 2015113
15 2008111
16
Association of the NAD(P)H:quinone oxidoreductase 609C-->T polymorphism with a decreased lung cancer risk.
1999111
17 2017105
18 201497
19 201495
20 202093

About Helen Chen

Helen Chen is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology, Oncology, Clinical Psychology and Epidemiology, having authored 239 papers that have together received 10.6k indexed citations. Recurring topics across this work include Maternal Mental Health During Pregnancy and Postpartum (44 papers), Child and Adolescent Psychosocial and Emotional Development (20 papers), Infant Development and Preterm Care (11 papers), Angiogenesis and VEGF in Cancer (8 papers), Engineering Education and Curriculum Development (7 papers), Cancer, Hypoxia, and Metabolism (7 papers), Machine Learning in Healthcare (5 papers) and Neuroendocrine Tumor Research Advances (5 papers). The work is most often cited by research in Cancer Research (1.5k citations), Oncology (1.9k citations), Molecular Biology (4.5k citations), Obstetrics and Gynecology (419 citations) and Hepatology (432 citations). Helen Chen has collaborated with scholars based in United States, Canada and Singapore. Frequent co-authors include Kenneth J. Hillan, K. Sue O’Shea, Lyn Powell-Braxton, Karen Carver-Moore, Mark W. Moore, Mary Dowd, Napoleone Ferrara, Lea T. Berleau, Hung Van Nguyen and Bruce A. Keyt. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE, Clinical Cancer Research, Journal of Affective Disorders and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact